MicroRNA-29 b-3 p prevents Schistosoma japonicum-induced liver fibrosis by targeting COL 1 A 1 and COL 3 A 1 † Running title : MiR-29 b-3 p & S . japonicum-induced liver fibrosis

[1]  A. Jun,et al.  MicroRNA-29b Overexpression Decreases Extracellular Matrix mRNA and Protein Production in Human Corneal Endothelial Cells , 2016, Cornea.

[2]  Qiang Zhang,et al.  Effect of reversine on cell cycle, apoptosis, and activation of hepatic stellate cells , 2016, Molecular and Cellular Biochemistry.

[3]  K. Yoshizato,et al.  MiR-29a Assists in Preventing the Activation of Human Stellate Cells and Promotes Recovery From Liver Fibrosis in Mice. , 2016, Molecular therapy : the journal of the American Society of Gene Therapy.

[4]  Feng-Sheng Wang,et al.  Microarray Study of Pathway Analysis Expression Profile Associated with MicroRNA-29a with Regard to Murine Cholestatic Liver Injuries , 2016, International journal of molecular sciences.

[5]  Katsunori Yoshida,et al.  Reversible Human TGF-β Signal Shifting between Tumor Suppression and Fibro-Carcinogenesis: Implications of Smad Phospho-Isoforms for Hepatic Epithelial-Mesenchymal Transitions , 2016, Journal of clinical medicine.

[6]  H. Qian,et al.  Expression of microRNA-454 in TGF-β1-stimulated hepatic stellate cells and in mouse livers infected with Schistosoma japonicum , 2014, Parasites & Vectors.

[7]  Liang Chen,et al.  Anti-fibrotic effect of Cordyceps sinensis polysaccharide: Inhibiting HSC activation, TGF-β1/Smad signalling, MMPs and TIMPs , 2013, Experimental biology and medicine.

[8]  Jun Wei,et al.  MicroRNA-21 activates hepatic stellate cells via PTEN/Akt signaling. , 2013, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[9]  K. Guo,et al.  miR-181b promotes hepatic stellate cells proliferation by targeting p27 and is elevated in the serum of cirrhosis patients. , 2012, Biochemical and biophysical research communications.

[10]  D. Epstein,et al.  Cross-talk between miR-29 and transforming growth factor-betas in trabecular meshwork cells. , 2011, Investigative ophthalmology & visual science.

[11]  Stefano Piccolo,et al.  MicroRNA control of signal transduction , 2010, Nature Reviews Molecular Cell Biology.

[12]  Jilong Shen,et al.  [The role of TGFbeta1 and IL-13 in cellular signal transduction of hepatic fibrosis of schistosomiasis]. , 2009, Zhongguo ji sheng chong xue yu ji sheng chong bing za zhi = Chinese journal of parasitology & parasitic diseases.

[13]  Guangcun Huang,et al.  Over‐expressed microRNA‐27a and 27b influence fat accumulation and cell proliferation during rat hepatic stellate cell activation , 2009, FEBS letters.

[14]  Oliver Hobert,et al.  Molecular architecture of a miRNA-regulated 3' UTR. , 2008, RNA.

[15]  O. Hammam,et al.  The pharmacological approach to reverse portal hypertention and hepatic schistosomal fibrosis in Egypt, control experimental study. , 2005, Journal of the Egyptian Society of Parasitology.

[16]  A. Gressner,et al.  The synthesis of proteoglycans in fat‐storing cells of rat liver , 1987, Hepatology.

[17]  M. Castellone,et al.  TGF-beta1, WNT, and SHH signaling in tumor progression and in fibrotic diseases. , 2017, Frontiers in bioscience.

[18]  Xiaowei Wang,et al.   MicroRNA-146b regulates hepatic stellate cell activation via targeting of KLF4. , 2016, Annals of hepatology.

[19]  P. Celichowski,et al.  [RNA processing - unusual mechanism of generation of novel classes of noncoding RNAs from functional RNAs]. , 2014, Postepy biochemii.

[20]  Q. Ning,et al.  Involvement of heat shock protein 47 in Schistosoma japonicum-induced hepatic fibrosis in mice. , 2014, International journal for parasitology.

[21]  Natalie J Torok,et al.  Liver fibrosis causes downregulation of miRNA-150 and miRNA-194 in hepatic stellate cells, and their overexpression causes decreased stellate cell activation. , 2010, American journal of physiology. Gastrointestinal and liver physiology.

[22]  P. Bioulac-Sage,et al.  [Mechanisms of hepatic fibrogenesis]. , 2002, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie.